US 12,272,438 B2
Modular witnessing device
Brendan John Burgess, Poway, CA (US); Magnus Roland Felke, San Diego, CA (US); Paul Anthony Preziotti, Coto de Caza, CA (US); Ramkumar Subramanian, San Diego, CA (US); Dugan Joyce, Chula Vista, CA (US); and Mustafa Yusufi, Escondido, CA (US)
Assigned to CareFusion 303, Inc., San Diego, CA (US)
Filed by CareFusion 303, Inc., San Diego, CA (US)
Filed on Feb. 23, 2021, as Appl. No. 17/183,128.
Claims priority of provisional application 62/980,517, filed on Feb. 24, 2020.
Prior Publication US 2021/0265032 A1, Aug. 26, 2021
Int. Cl. G16H 20/13 (2018.01); A61J 1/14 (2023.01); G16H 40/20 (2018.01); G16H 40/40 (2018.01); G16H 40/67 (2018.01)
CPC G16H 20/13 (2018.01) [A61J 1/1437 (2013.01); G16H 40/20 (2018.01); G16H 40/40 (2018.01); G16H 40/67 (2018.01)] 17 Claims
OG exemplary drawing
 
1. A system for witnessing wasting a medication, the system comprising:
at least one data processor, and at least one memory storing instructions which, when executed by the at least one data processor, result in operations comprising:
authenticating, at a witnessing device, a clinician, wherein the witnessing device comprises or is comprised in the at least one data processor and the at least one memory;
receiving, at the witnessing device, a request to perform a medical workflow, wherein the medical workflow comprises a series of one or more steps for wasting the medication;
determining, at the witnessing device and based at least in part on the medical workflow, that a witness is required to observe the medical workflow;
in response to the determining that the witness is required, initiating, by the witnessing device at a witnessing client, a witnessing session at the witnessing client configured to allow the witness to remotely observe the medical workflow; and
in response to at least the initiation of the witnessing session, enabling, by the witnessing device, completion of the medical workflow by providing a command to at least one companion device to enable wasting of the medication by unlocking the at least one companion device;
determining an elapsed time from the unlocking of the at least one companion device and/or wasting of the medication is completed; and
relocking the at least one companion device to prevent access to the at least one companion device responsive to the elapsed time.